A Study of Neoadjuvant Dostarlimab Plus Capecitabine Plus Oxaliplatin (CAPEOX) Vs CAPEOX With Previously Untreated T4N0 or Stage III Mismatch Repair Proficient (MMRp)/Microsatellite Stable (MSS) Colon Cancer

120 participants · First posted Aug 23, 2024

Phase II Clinical Study of AC591 in Preventing Oxaliplatin-Induced Peripheral Neuropathy

120 participants · First posted Dec 9, 2024

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

55 participants · First posted Aug 28, 2023

Floxuridine

<dd class="col-xl-8 col-md-9 col-sm-8">C₉H₁₁FN₂O₅</dd> · Rx

Fruquintinib(Fruzaqla)

C₂₁H₁₉N₃O₅ · Rx

Candonilimab

Rx

CareDx

United States

CAPTOR THERAPEUTICS S A

Poland

CAPIO MEDIA PTY LTD

Australia

GSK Advances Dostarlimab in Phase 3 Colon Cancer Trial and Phase 2 Endometrial Cancer Study

Anlotinib Plus Chemotherapy Shows Promise in Advanced Gastrointestinal Cancers

Watch-and-Wait Strategy Safe for Rectal Cancer Responders After Total Neoadjuvant Therapy